{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:06:09Z","timestamp":1791846369438,"version":"4.3.4"},"reference-count":172,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T00:00:00Z","timestamp":1717286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The placenta plays a key role in several adverse obstetrical outcomes, such as preeclampsia, intrauterine growth restriction and gestational diabetes mellitus. The early identification of at-risk pregnancies could significantly improve the management, therapy and prognosis of these pregnancies, especially if these at-risk pregnancies are identified in the first trimester. The aim of this review was to summarize the possible biomarkers that can be used to diagnose early placental dysfunction and, consequently, at-risk pregnancies. We divided the biomarkers into proteins and non-proteins. Among the protein biomarkers, some are already used in clinical practice, such as the sFLT1\/PLGF ratio or PAPP-A; others are not yet validated, such as HTRA1, Gal-3 and CD93. In the literature, many studies analyzed the role of several protein biomarkers, but their results are contrasting. On the other hand, some non-protein biomarkers, such as miR-125b, miR-518b and miR-628-3p, seem to be linked to an increased risk of complicated pregnancy. Thus, a first trimester heterogeneous biomarkers panel containing protein and non-protein biomarkers may be more appropriate to identify and discriminate several complications that can affect pregnancies.<\/jats:p>","DOI":"10.3390\/ijms25116136","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T10:06:01Z","timestamp":1717409161000},"page":"6136","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["First Trimester Placental Biomarkers for Pregnancy Outcomes"],"prefix":"10.3390","volume":"25","author":[{"given":"Martina","family":"Cristodoro","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072 Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9845-7744","authenticated-orcid":false,"given":"Martina","family":"Messa","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072 Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7003-1230","authenticated-orcid":false,"given":"Giovanni","family":"Tossetta","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Universit\u00e0 Politecnica delle Marche, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2267-0270","authenticated-orcid":false,"given":"Daniela","family":"Marzioni","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Universit\u00e0 Politecnica delle Marche, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinella","family":"Dell\u2019Avanzo","sequence":"additional","affiliation":[{"name":"Humanitas San Pio X, Via Francesco Nava 31, 20159 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Inversetti","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072 Milano, Italy"},{"name":"IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1273-3335","authenticated-orcid":false,"given":"Nicoletta","family":"Di Simone","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072 Milano, Italy"},{"name":"IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"A124","DOI":"10.1289\/ehp.124-A124","article-title":"Lasting Impact of an Ephemeral Organ: The Role of the Placenta in Fetal Programming","volume":"124","author":"Konkel","year":"2016","journal-title":"Environ. Heal. Perspect."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1530\/REP-09-0092","article-title":"Regulation of vascular growth and function in the human placenta","volume":"138","author":"Burton","year":"2009","journal-title":"Reproduction"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Burton, G.J., and Fowden, A.L. (2015). The placenta: A multifaceted, transient organ. Philos. Trans. R. Soc. B Biol. Sci., 370.","DOI":"10.1098\/rstb.2014.0066"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3389\/fphys.2018.01091","article-title":"The Role of Placental Hormones in Mediating Maternal Adaptations to Support Pregnancy and Lactation","volume":"9","author":"Napso","year":"2018","journal-title":"Front. Physiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1016\/j.ajog.2015.08.042","article-title":"Why is placentation abnormal in preeclampsia?","volume":"213","author":"Fisher","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0143-4004(05)80193-6","article-title":"Histological study of the materno-embryonic interface in spontaneous abortion","volume":"11","author":"Hustin","year":"1990","journal-title":"Placenta"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bpobgyn.2011.02.006","article-title":"Placental bed disorders in preterm labor, preterm PROM, spontaneous abortion and abruptio placentae","volume":"25","author":"Romero","year":"2011","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1471-0528.1991.tb13450.x","article-title":"Placental bed spiral arteries in the hypertensive disorders of pregnancy","volume":"98","author":"Pijnenborg","year":"1991","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Olmos-Ortiz, A., Flores-Espinosa, P., D\u00edaz, L., Vel\u00e1zquez, P., Ram\u00edrez-Isarraraz, C., and Zaga-Clavellina, V. (2021). Immunoendocrine Dysregulation during Gestational Diabetes Mellitus: The Central Role of the Placenta. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22158087"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"650328","DOI":"10.3389\/fendo.2021.650328","article-title":"FKBPL and SIRT-1 Are Downregulated by Diabetes in Pregnancy Impacting on Angiogenesis and Endothelial Function","volume":"12","author":"Alqudah","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Carrasco-Wong, I., Moller, A., Giachini, F.R., Lima, V.V., Toledo, F., Stojanova, J., Sobrevia, L., and Mart\u00edn, S.S. (2020). Placental structure in gestational diabetes mellitus. Biochim. Biophys. Acta (BBA)\u2014Mol. Basis Dis., 1866.","DOI":"10.1016\/j.bbadis.2019.165535"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S954","DOI":"10.1016\/j.ajog.2020.10.024","article-title":"The placenta and preeclampsia: Villain or victim?","volume":"226","author":"Melchiorre","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Jena, M.K., Sharma, N.R., Petitt, M., Maulik, D., and Nayak, N.R. (2020). Pathogenesis of Preeclampsia and Therapeutic Approaches Targeting the Placenta. Biomolecules, 10.","DOI":"10.3390\/biom10060953"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Tossetta, G., Fantone, S., Piani, F., Crescimanno, C., Ciavattini, A., Giannubilo, S.R., and Marzioni, D. (2023). Modulation of NRF2\/KEAP1 Signaling in Preeclampsia. Cells, 12.","DOI":"10.3390\/cells12111545"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41574-020-0372-6","article-title":"Tracking placental development in health and disease","volume":"16","author":"Aplin","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ajog.2016.03.001","article-title":"Placental origins of adverse preg-nancy out-comes: Potential molecular targets: An executive workshop summary of the eunice Kennedy Shriver Na-tional Institute of child Health and human development","volume":"215","author":"Ilekis","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/aogs.13834","article-title":"Devel-opment of placental abnormalities in location and anatomy","volume":"99","author":"Jansen","year":"2020","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_18","unstructured":"American College of Obstetricians and Gynecologists (2013). Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy. Obstet. Gynecol., 122, 1122\u20131131."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"9.23.1","DOI":"10.1002\/cpph.19","article-title":"Biomarkers\u2014A General Review","volume":"76","author":"Aronson","year":"2017","journal-title":"Curr. Protoc. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/AOG.0b013e3181719b7a","article-title":"Effective Prediction of Preeclampsia by a Combined Ratio of Angiogenesis-Related Factors","volume":"111","author":"Lim","year":"2008","journal-title":"Obstet. Gynecol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000477903","article-title":"Update on the diagnosis and prognosis of preeclampsia with the aid of the sFlt-1\/PlGF ratio in singleton pregnancies","volume":"43","author":"Herraiz","year":"2018","journal-title":"Fetal Diagn. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/HYPERTENSIONAHA.120.15338","article-title":"Total Versus Free Placental Growth Factor Levels in the Pathogenesis of Preeclampsia","volume":"76","author":"Lecarpentier","year":"2020","journal-title":"Hypertension"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejogrb.2014.09.027","article-title":"Abnormal blood biomarkers in early pregnancy are as-sociated with preeclampsia: A meta-analysis","volume":"182","author":"Allen","year":"2014","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/AOG.0000000000000367","article-title":"Characterization of the soluble fms-like tyro-sine kinase-1 to placental growth factor ratio in pregnancies complicated by fetal growth restriction","volume":"124","author":"Herraiz","year":"2014","journal-title":"Obstet. Gynecol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"520.e1","DOI":"10.1016\/j.ajog.2021.04.232","article-title":"Slowing of fetal growth and elevated maternal serum sFLT1:PlGF are associated with early term spontaneous labor","volume":"225","author":"Sovio","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1161\/CIRCULATIONAHA.113.003215","article-title":"Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: A prospective multicenter study","volume":"128","author":"Chappell","year":"2013","journal-title":"Circulation"},{"key":"ref_27","unstructured":"The Fetal Medicine Foundation (2021, June 10). Risk Assessment: Risk for Preeclampsia. Available online: https:\/\/fetalmedicine.org\/research\/assess\/preeclampsia\/first-trimester."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating Angiogenic Factors and the Risk of Preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ajog.2020.11.007","article-title":"Performance of soluble fms-like tyrosine kinase-1-to-placental growth factor ratio of \u226585 for ruling in preeclampsia within 4\u2009weeks","volume":"224","author":"Cerdeira","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_30","unstructured":"NICE (2021, July 20). PlGF-Based Testing to Help Diagnose Suspected Preeclampsia (Triage PlGF Test, Elecsys Immunoassay sFlt-1\/PlGF ra-Tio, DELFIA Xpress PlGF 1-2-3 Test, and BRAHMS sFlt-1 Kryptor\/BRAHMS PlGF Plus Kryptor PE Ratio). Diagnostics Guidance [DG23]. Available online: https:\/\/www.nice.org.uk\/guidance\/dg23\/."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/uog.26032","article-title":"Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction","volume":"61","author":"Stepan","year":"2023","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_32","first-page":"CD012600","article-title":"First trimester ultrasound tests alone or in combina-tion with first trimester serum tests for Down\u2019s syndrome screening","volume":"2017","author":"Alldred","year":"1996","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1210\/endrev\/bnad017","article-title":"The Pregnancy-Associated Plasma Protein-A (PAPP-A) Story","volume":"44","author":"Conover","year":"2023","journal-title":"Endocr. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1038\/s41598-020-61830-5","article-title":"First trimester PAPP-A serum levels and long-term metabolic outcome of mothers and their offspring","volume":"10","author":"Fruscalzo","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_35","first-page":"1788","article-title":"Correlation analysis of serum placental growth factor, pregnancy-related plasma protein-A and disease severity in patients with hypertensive disorder in pregnancy","volume":"25","author":"Sun","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Shahsavandi, E., Movahedi, M., Khanjani, S., Shahshahan, Z., Hajihashemi, M., and Farahbod, F. (2023). Evaluation of the relationship between pregnancy-associated plasma protein A (PAPP-A) and pregnancy outcomes. Adv. Biomed. Res., 12.","DOI":"10.4103\/abr.abr_344_21"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S1701-2163(16)32973-5","article-title":"Obstetrical complications assoicated with abnormal maternal serum marker analytes","volume":"30","author":"Gagnon","year":"2008","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"ref_38","first-page":"9955","article-title":"Elevated first-trimester PAPP-A is a marker in high-risk pregnancies with an increased risk of placenta accreta in predicting adverse outcomes","volume":"27","author":"Balkans","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_39","first-page":"1761","article-title":"Association of pregnancy-associated plasma protein A and vascular endothelial growth fac-tor with pregnancy-induced hypertension","volume":"18","author":"Xu","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Cole, L.A. (2010). Biological functions of hCG and hCG-related molecules. Reprod. Biol. Endocrinol., 8.","DOI":"10.1186\/1477-7827-8-102"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.placenta.2020.10.005","article-title":"The role of \u03b2-HCG and VEGF-MEK\/ERK signaling pathway in villi angiogenesis in patients with missed abortion","volume":"103","author":"Jing","year":"2020","journal-title":"Placenta"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1096\/fj.06-5885fje","article-title":"Angiogenic activity of human chorionic gonadotropin through LH receptor activation on endothelial and epithelial cells of the endometrium","volume":"20","author":"Berndt","year":"2006","journal-title":"FASEB J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.mce.2006.11.015","article-title":"The gonadotropins: Tissue-specific angiogenic factors?","volume":"269","author":"Reisinger","year":"2007","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/s41598-023-28561-9","article-title":"Extreme \u03b2HCG levels in first trimester screening are risk factors for adverse maternal and fetal outcomes","volume":"13","author":"Younesi","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Visconti, F., Quaresima, P., Chiefari, E., Caroleo, P., Arcidiacono, B., Puccio, L., Mirabelli, M., Foti, D.P., Di Carlo, C., and Vero, R. (2019). First Trimester Combined Test (FTCT) as a Predictor of Gestational Diabetes Mellitus. Int. J. Environ. Res. Public Health, 16.","DOI":"10.3390\/ijerph16193654"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.3109\/14767058.2012.684170","article-title":"Association between pregnancy-associated plasma protein-A and gestational diabetes requiring insulin treatment at 11\u201314 weeks of gestation","volume":"25","author":"Husslein","year":"2012","journal-title":"J. Matern. Neonatal Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"619530","DOI":"10.3389\/fendo.2021.619530","article-title":"Predictive Performance of Serum \u03b2-hCG MoM Levels for Preeclampsia Screening: A Meta-Analysis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000151344","article-title":"Longitudinal Determination of Serum Placental Protein 13 during Development of Preeclampsia","volume":"24","author":"Huppertz","year":"2008","journal-title":"Fetal Diagn. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3389\/fimmu.2014.00348","article-title":"Placental Protein 13 (PP13)\u2014A Placental Immunoregulatory Galectin Protecting Pregnancy","volume":"5","author":"Than","year":"2014","journal-title":"Front. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Gadde, R., Cd, D., and Sheela, S. (2018). Placental protein 13: An important biological protein in preeclampsia. J. Circ. Biomark., 7.","DOI":"10.33393\/jcb.2018.2091"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/etm.2022.11297","article-title":"Predictive performance of first trimester serum galectin-13\/PP-13 in preeclampsia screening: A systematic review and meta-analysis","volume":"23","author":"Vasilache","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.placenta.2020.08.020","article-title":"First trimester biomarkers for prediction of gestational diabetes mellitus","volume":"101","author":"Binyamin","year":"2020","journal-title":"Placenta"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Biadasiewicz, K., Fock, V., Dekan, S., Proestling, K., Velicky, P., Haider, S., Kn\u00f6fler, M., Fr\u00f6hlich, C., and Pollheimer, J. (2014). Extravillous Trophoblast-Associated ADAM12 Exerts Pro-Invasive Properties, Including Induction of Integrin Beta 1-Mediated Cellular Spreading1. Biol. Reprod., 90.","DOI":"10.1095\/biolreprod.113.115279"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"932480","DOI":"10.3389\/fcvm.2022.932480","article-title":"Novel Early Pregnancy Multimarker Screening Test for Preeclampsia Risk Prediction","volume":"9","author":"Ratnik","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tjog.2017.01.009","article-title":"First trimester maternal serum analytes and second trimester uterine artery Doppler in the prediction of preeclampsia and fetal growth restriction","volume":"56","author":"Yu","year":"2017","journal-title":"Taiwan. J. Obstet. Gynecol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000321694","article-title":"Prediction of small-for-gestation neonates from bio-physical and biochemical markers at 11\u201313 weeks","volume":"29","author":"Karagiannis","year":"2011","journal-title":"Fetal Diagn. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/pd.1665","article-title":"First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system","volume":"27","author":"Cowans","year":"2007","journal-title":"Prenat. Diagn."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2021.11.001","article-title":"A disintegrin and metalloproteinase 12 (ADAM12) is reduced at 36 weeks\u2019 gestation in pregnancies destined to deliver small for gestational age infants","volume":"117","author":"Andres","year":"2022","journal-title":"Placenta"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"43","DOI":"10.12891\/ceog2000.2016","article-title":"Predictive value of biochemical marker AD-AM-12 at first trimester of pregnancy for hypertension and intrauterine growth restriction","volume":"43","author":"Kasimis","year":"2016","journal-title":"Clin. Exp. Obstet. Gynecol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00404-016-4024-y","article-title":"Evaluation of biochemical markers combined with uterine artery Doppler parameters in fetuses with growth restriction: A case\u2013control study","volume":"294","author":"Zamarian","year":"2016","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0026-0495(98)90195-0","article-title":"Sex hormone-binding globulin and insulin resistance in African-American women","volume":"47","author":"Sherif","year":"1998","journal-title":"Metabolism"},{"key":"ref_62","first-page":"56","article-title":"Decreased sex hormone-binding globulin predicts noninsulin dependent diabetes mellitus in wom-en but not in men","volume":"77","author":"Haffner","year":"1993","journal-title":"Endocr. Soc."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.beem.2015.06.005","article-title":"The biomarker sex hormone-binding globulin\u2014From established applications to emerging trends in clinical medicine","volume":"29","author":"Thaler","year":"2015","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1056\/NEJMoa0804381","article-title":"Sex hormone-binding globulin and risk of type 2 diabe-tes in women and men","volume":"361","author":"Ding","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tem.2011.09.005","article-title":"Sex hormone-binding globulin and type 2 diabetes mellitus","volume":"23","author":"Le","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1080\/01443615.2022.2114321","article-title":"First trimester sex hormone-binding globulin predicts gestational diabetes mellitus in a population of Nigerian women","volume":"42","author":"Basil","year":"2022","journal-title":"J. Obstet. Gynaecol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2217\/bmm-2016-0030","article-title":"Sex hormone-binding globulin levels during the first trimester may predict gestational diabetes mellitus development","volume":"12","author":"Zhang","year":"2018","journal-title":"Biomark. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1515\/jpm-2018-0120","article-title":"First trimester prediction of gestational diabetes mellitus using plasma biomarkers: A case-control study","volume":"47","author":"Correa","year":"2018","journal-title":"Jpme"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000515085","article-title":"Changes of Serum Sex Hormone-Binding Globulin, Homocysteine, and Hypersensitive CRP Levels during Pregnancy and Their Relationship with Gestational Diabetes Mellitus","volume":"86","author":"Liu","year":"2021","journal-title":"Gynecol. Obstet. Investig."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.diabres.2019.04.028","article-title":"Sex hormone binding globulin for prediction of gestational diabetes mellitus in pre-conception and pregnancy: A systematic review","volume":"152","author":"Faal","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/1933719116667230","article-title":"First Trimester Maternal Glycated Hemoglobin and Sex Hormone-Binding Globulin Do Not Predict Third Trimester Glucose Intolerance of Pregnancy","volume":"24","author":"Berggren","year":"2016","journal-title":"Reprod. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"14532","DOI":"10.1021\/bi026513v","article-title":"Characterization of the Vitamin E-Binding Properties of Human Plasma Afamin","volume":"41","author":"Voegele","year":"2002","journal-title":"Biochemistry"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000343106","article-title":"A History of Vitamin E","volume":"61","author":"Niki","year":"2012","journal-title":"Ann. Nutr. Metab."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00404-018-4897-z","article-title":"Afamin: An early predictor of preeclampsia","volume":"298","author":"Koeninger","year":"2018","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_75","first-page":"1","article-title":"Is Afamin a novel biomarker for gestational diabetes mellitus? A pilot study","volume":"16","author":"Mathan","year":"2018","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cca.2017.11.031","article-title":"First trimester serum afamin concentrations are associated with the development of pre-eclampsia and gestational diabetes mellitus in pregnant women","volume":"476","author":"Tramontana","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1590\/1806-9282.20221115","article-title":"Evaluation of first- and third-trimester afamin levels in preeclampsia","volume":"69","author":"Unver","year":"2023","journal-title":"Rev. Assoc. Med. Bras."},{"key":"ref_78","first-page":"2006","article-title":"Is afamin a potential early biomarker for subsequent development of preeclampsia? A nested case\u2013control study","volume":"34","author":"Celik","year":"2020","journal-title":"J. Matern. Neonatal Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1157114","DOI":"10.3389\/fendo.2023.1157114","article-title":"Serum afamin levels in predicting gestational diabetes mellitus and preeclampsia: A systematic review and meta-analysis","volume":"14","author":"Yuan","year":"2023","journal-title":"Front. Endocrinol."},{"key":"ref_80","first-page":"23","article-title":"Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological insights and po-tent clinical biomarker of metabolic and cardiovascular diseases","volume":"8","author":"Furuhashi","year":"2015","journal-title":"Clin. Med. Insights Cardiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1111\/dom.15214","article-title":"Adipose tissue-derived FABP4 mediates glucagon-stimulated hepatic glucose production in gestational diabetes","volume":"25","author":"Ron","year":"2023","journal-title":"Diabetes Obes. Metab."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"L227","DOI":"10.1152\/ajplung.00429.2017","article-title":"FABP4 regulates eosinophil recruitment and activation in allergic airway inflammation","volume":"315","author":"Bastan","year":"2018","journal-title":"Am. J. Physiol. Cell. Mol. Physiol."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Shi, Y., Wang, C.-C., Wu, L., Zhang, Y., Xu, A., and Wang, Y. (2023). Pathophysiological Insight into Fatty Acid-Binding Protein-4: Multifaced Roles in Reproduction, Pregnancy, and Offspring Health. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241612655"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/s41440-023-01553-y","article-title":"Serum fatty acid binding protein 4 and Doppler of uterine artery ultrasound in the first trimester for the prediction of preeclampsia","volume":"47","author":"Paiboonborirak","year":"2024","journal-title":"Hypertens. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"E349","DOI":"10.1210\/jc.2011-2276","article-title":"Maternal Serum Fatty Acid Binding Protein 4 (FABP4) and the Development of Preeclampsia","volume":"97","author":"Scifres","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"6681432","DOI":"10.1155\/2021\/6681432","article-title":"Risk of Gestational Diabetes Mellitus in relation to Plasma Concentrations of Fatty Acid-Binding Protein 4: A Nested Case-Control Study in China","volume":"2021","author":"Jin","year":"2021","journal-title":"J. Diabetes Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.metabol.2017.08.003","article-title":"Maternal circulating adipokine profile and insulin resistance in women at high risk of developing gestational diabetes mellitus","volume":"75","author":"Guelfi","year":"2017","journal-title":"Metabolism"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"800","DOI":"10.21474\/IJAR01\/6496","article-title":"Serum adropin and adipose fatty-acid binding protein at 6th week of pregnancy are significant predictors for development of insulin resistance at the 24th week","volume":"6","author":"Sharafeldeen","year":"2018","journal-title":"Int. J. Adv. Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/AOG.0000000000002310","article-title":"First-Trimester Serum Fatty Acid-Binding Protein 4 and Subsequent Gestational Diabetes Mellitus","volume":"130","author":"Tu","year":"2017","journal-title":"Obstet. Gynecol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e001333","DOI":"10.1136\/bmjdrc-2020-001333","article-title":"Adipokines in early and mid-pregnancy and subsequent risk of gestational diabetes: A longitudinal study in a multiracial cohort","volume":"8","author":"Francis","year":"2020","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/jdi.12484","article-title":"Changes in serum adipocyte fatty acid-binding protein in women with gestational diabetes mellitus and normal pregnant women during mid- and late pregnancy","volume":"7","author":"Zhang","year":"2016","journal-title":"J. Diabetes Investig."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.2337\/dc11-0715","article-title":"Gestational Diabetes Mellitus Causes Changes in the Concentrations of Adipocyte Fatty Acid\u2013Binding Protein and Other Adipocytokines in Cord Blood","volume":"34","author":"Meitzner","year":"2011","journal-title":"Diabetes Care"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"101549","DOI":"10.1016\/j.tice.2021.101549","article-title":"HTRA family proteins in pregnancy outcome","volume":"72","author":"Fantone","year":"2021","journal-title":"Tissue Cell"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.4081\/ejh.2015.2570","article-title":"High Temperature Requirement A1, Transforming Growth Factor Beta 1, phosphoSmad2 and Ki67 in Eutopic and Ectopic Endometrium of Women with Endometriosis","volume":"59","author":"Goteri","year":"2015","journal-title":"Eur. J. Histochem."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3892\/or.2017.5700","article-title":"Low HtrA1 expression in patients with long-standing ulcerative colitis and colorectal cancer","volume":"38","author":"Altobelli","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"116350","DOI":"10.1016\/j.bone.2022.116350","article-title":"The multifaced role of HtrA1 in the development of joint and skeletal disorders","volume":"157","author":"Tossetta","year":"2022","journal-title":"Bone"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"102329","DOI":"10.1016\/j.tice.2024.102329","article-title":"Possible involvement of HtrA1 serine protease in the onset of osteoporotic bone extracellular matrix changes","volume":"87","author":"Licini","year":"2024","journal-title":"Tissue Cell"},{"key":"ref_98","first-page":"2724","article-title":"High temperature requirement A1 and fibronectin: Two possible players in placental tissue remodelling","volume":"60","author":"Tossetta","year":"2016","journal-title":"Eur. J. Histochem."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1369\/jhc.3A6186.2004","article-title":"The Serine Protease HtrA1 Is Upregulated in the Human Placenta during Pregnancy","volume":"52","author":"Fedele","year":"2004","journal-title":"J. Histochem. Cytochem."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1074\/jbc.M111.275990","article-title":"High Temperature Requirement Factor A1 (HTRA1) Gene Regulates Angiogenesis through Transforming Growth Factor-\u03b2 Family Member Growth Differentiation Factor 6","volume":"287","author":"Zhang","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.3390\/cimb45050246","article-title":"HTRA1 in Placental Cell Models: A Possible Role in Preeclampsia","volume":"45","author":"Tossetta","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.preghy.2019.08.005","article-title":"Association between first trimester plasma htra1 level and subsequent preeclampsia: A possible early marker?","volume":"18","author":"Gesuita","year":"2019","journal-title":"Pregnancy Hypertens."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Tossetta, G., Fantone, S., Gesuita, R., Di Renzo, G.C., Meyyazhagan, A., Tersigni, C., Scambia, G., Di Simone, N., and Marzioni, D. (2022). HtrA1 in Gestational Diabetes Mellitus: A Possible Biomarker?. Diagnostics, 12.","DOI":"10.3390\/diagnostics12112705"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1080\/14767058.2020.1732345","article-title":"First trimester HtrA1 maternal plasma level and spontaneous preterm birth","volume":"35","author":"Giannubilo","year":"2022","journal-title":"J. Matern. Neonatal Med."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Tossetta, G., Piani, F., Borghi, C., and Marzioni, D. (2023). Role of CD93 in Health and Disease. Cells, 12.","DOI":"10.3390\/cells12131778"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00441-021-03543-3","article-title":"CD93 a potential player in cytotrophoblast and endothelial cell migration","volume":"387","author":"Fantone","year":"2021","journal-title":"Cell Tissue Res."},{"key":"ref_107","first-page":"591","article-title":"First Trimester CD93 as a Novel Marker of Preeclampsia and Its Complications: A Pilot Study. High Blood Press","volume":"30","author":"Piani","year":"2023","journal-title":"Cardiovasc. Prev."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"13145","DOI":"10.1038\/s41598-019-49511-4","article-title":"Association between Galectin-3 levels within central and peripheral venous blood, and adverse left ventricular remodelling after first acute myocardial infarction","volume":"9","author":"Andrejic","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.ajpath.2013.01.017","article-title":"Galectin-3 Accelerates M2 Macrophage Infiltration and Angiogenesis in Tumors","volume":"182","author":"Jia","year":"2013","journal-title":"Am. J. Pathol."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Talmor-Barkan, Y., Chezar-Azerrad, C., Kruchin, B., Leshem-Lev, D., Levi, A., Hadar, E., Kornowski, R., Tenenbaum-Gavish, K., and Porter, A. (2020). Elevated galectin-3 in women with gestational diabetes mellitus, a new surrogate for cardiovascular disease in women. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0234732"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s40618-014-0222-2","article-title":"Increased levels of galectin-3 were associated with prediabetes and diabetes: New risk factor?","volume":"38","author":"Yilmaz","year":"2014","journal-title":"J. Endocrinol. Investig."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.cell.2016.10.025","article-title":"Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance","volume":"167","author":"Li","year":"2016","journal-title":"Cell"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-015-0230-3","article-title":"Galectin-3 deficiency exacerbates hyperglycemia and the endothelial response to diabetes","volume":"14","author":"Darrow","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.numecd.2021.03.002","article-title":"Enhanced expression of Galectin-3 in gestational diabetes","volume":"31","author":"Heusler","year":"2021","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41419-020-02791-5","article-title":"Galectin-3 deficiency in pregnancy increases the risk of fetal growth restriction (FGR) via placental insufficiency","volume":"11","author":"Freitag","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s10020-023-00707-5","article-title":"Elevated galectin-3 levels detected in women with hyperglycemia during early and mid-pregnancy antagonizes high glucose\u2014Induced trophoblast cells apoptosis via galectin-3\/foxc1 pathway","volume":"29","author":"Deng","year":"2023","journal-title":"Mol. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1172\/JCI112752","article-title":"Intravascular release of intact cellular fibronectin during oxidant-induced injury of the in vitro perfused rabbit lung","volume":"78","author":"Peters","year":"1986","journal-title":"J. Clin. Investig."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.bi.57.070188.002111","article-title":"FIBRONECTIN AND ITS RECEPTORS","volume":"57","author":"Ruoslahti","year":"1988","journal-title":"Annu. Rev. Biochem."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/0002-9378(90)90385-K","article-title":"Increased plasma levels of ED1+ cellular fibronectin precede the clinical signs of preeclampsia","volume":"162","author":"Lockwood","year":"1990","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00404-020-05670-8","article-title":"Glycosylated fibronectin as a first trimester marker for gestational diabetes","volume":"302","author":"Alanen","year":"2020","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature11233","article-title":"Landscape of transcription in human cells","volume":"489","author":"Djebali","year":"2012","journal-title":"Nature"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Monteiro, L.J., Pe\u00f1ailillo, R., S\u00e1nchez, M., Acu\u00f1a-Gallardo, S., M\u00f6nckeberg, M., Ong, J., Choolani, M., Illanes, S.E., and Nardocci, G. (2021). The Role of Long Non-Coding RNAs in Trophoblast Regulation in Preeclampsia and Intrauterine Growth Restriction. Genes, 12.","DOI":"10.3390\/genes12070970"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Kannampuzha, S., Ravichandran, M., Mukherjee, A.G., Wanjari, U.R., Renu, K., Vellingiri, B., Iyer, M., Dey, A., George, A., and Gopalakrishnan, A.V. (2022). The mechanism of action of non-coding RNAs in placental disorders. Biomed. Pharmacother., 156.","DOI":"10.1016\/j.biopha.2022.113964"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cell.2014.03.008","article-title":"The Noncoding RNA Revolution\u2014Trashing Old Rules to Forge New Ones","volume":"157","author":"Cech","year":"2014","journal-title":"Cell"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ab.2016.01.025","article-title":"Protocol for miRNA isolation from biofluids","volume":"499","author":"Lekchnov","year":"2016","journal-title":"Anal. Biochem."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"17442","DOI":"10.1074\/jbc.M110.107821","article-title":"Secretory mechanisms and intercellular transfer of MicroRNAs in living cells","volume":"285","author":"Kosaka","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases","volume":"18","author":"Chen","year":"2008","journal-title":"Cell Res."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.3390\/ijms14035519","article-title":"MicroRNAs in Human Placental Development and Pregnancy Complications","volume":"14","author":"Fu","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Sun, N., Qin, S., Zhang, L., and Liu, S. (2021). Roles of noncoding RNAs in preeclampsia. Reprod. Biol. Endocrinol., 19.","DOI":"10.1186\/s12958-021-00783-4"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Xu, P., Ma, Y., Wu, H., and Wang, Y.-L. (2021). Placenta-Derived MicroRNAs in the Pathophysiology of Human Pregnancy. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.646326"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2152615","DOI":"10.1080\/15592294.2022.2152615","article-title":"Circulating miRNAs in the first trimester and pregnancy complications: A systematic review","volume":"18","author":"Subramanian","year":"2022","journal-title":"Epigenetics"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41420-020-0269-0","article-title":"Elevated microRNA-125b inhibits cytotrophoblast invasion and impairs endothelial cell function in preeclampsia","volume":"6","author":"Li","year":"2020","journal-title":"Cell Death Discov."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.trsl.2020.07.011","article-title":"Pre-eclampsia predictive ability of maternal miR-125b: A clinical and experimental study","volume":"228","author":"Licini","year":"2020","journal-title":"Transl. Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1080\/10799893.2020.1806318","article-title":"MiR-125b participates in the occurrence of preeclampsia by regulating the migration and invasion of extravillous trophoblastic cells through STAT3 signaling pathway","volume":"41","author":"Tang","year":"2021","journal-title":"J. Recept. Signal Transduct."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Hromadnikova, I., Kotlabova, K., Ivankova, K., and Krofta, L. (2017). First trimester screening of circulating C19MC microRNAs and the evaluation of their potential to predict the onset of preeclampsia and IUGR. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0171756"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Hromadnikova, I., Kotlabova, K., Hympanova, L., Doucha, J., and Krofta, L. (2014). First trimester screening of circulating C19MC mi-croRNAs can predict subsequent onset of gestational hypertension. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0113735"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.tjog.2014.03.001","article-title":"Potential role of circulating microRNAs as early markers of preeclampsia","volume":"53","author":"Ura","year":"2014","journal-title":"Taiwan. J. Obstet. Gynecol."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Martinez-Fierro, M.L., and Garza-Veloz, I. (2021). Analysis of Circulating microRNA Signatures and Preeclampsia Development. Cells, 10.","DOI":"10.3390\/cells10051003"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.preghy.2019.03.012","article-title":"Serum levels of miR-628-3p and miR-628-5p during the early pregnancy are increased in women who subsequently develop preeclampsia","volume":"16","author":"Luevano","year":"2019","journal-title":"Pregnancy Hypertens."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/jog.12749","article-title":"Circulating chromosome 19 miRNA cluster microRNAs in pregnant women with severe pre-eclampsia","volume":"41","author":"Miura","year":"2015","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Kim, S.H., MacIntyre, D.A., Binkhamis, R., Cook, J., Sykes, L., Bennett, P.R., and Terzidou, V. (2020). Maternal plasma miRNAs as potential biomarkers for detecting risk of small-for-gestational-age births. EBioMedicine, 62.","DOI":"10.1016\/j.ebiom.2020.103145"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.1038\/s41598-019-42166-1","article-title":"First Trimester Circulating MicroRNA Biomarkers Predictive of Subsequent Preterm Delivery and Cervical Shortening","volume":"9","author":"Cook","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"839344","DOI":"10.3389\/fendo.2022.839344","article-title":"miRNAs as Predictive Factors in Early Diagnosis of Gestational Diabetes Mellitus","volume":"13","author":"Juchnicka","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"11230","DOI":"10.1074\/jbc.M113.544999","article-title":"Insulin receptor substrate 1\/2 (IRS1\/2) regulates Wnt\/\u03b2-Catenin sig-naling through blocking autophagic degradation of dishevelled","volume":"289","author":"Geng","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/oby.21709","article-title":"Circulating adipocyte-derived exosomal MicroRNAs associated with decreased insulin resistance after gastric bypass","volume":"25","author":"Hubal","year":"2016","journal-title":"Obesity"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijgo.2015.01.010","article-title":"Profiling maternal plasma microRNA expression in early pregnancy to predict gestational diabetes mellitus","volume":"130","author":"Zhu","year":"2015","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/jog.13317","article-title":"Plasma microRNA-16-5p, -17-5p and -20a-5p: Novel diagnostic biomarkers for gestational diabetes mellitus","volume":"43","author":"Cao","year":"2017","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrendo.2013.157","article-title":"The role of FOXO1 in \u03b2-cell failure and type 2 diabetes mellitus","volume":"9","author":"Kitamura","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Collares, C.V., Evangelista, A.F., Xavier, D.J., Rassi, D.M., Arns, T., Foss-Freitas, M.C., and Donadi, E.A. (2013). Identifying common and specific mi-croRNAs expressed in peripheral blood mononuclear cell of type 1, type 2, and gestational diabetes mellitus patients. BMC Res Notes., 6.","DOI":"10.1186\/1756-0500-6-491"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3389\/fendo.2018.00132","article-title":"Identification of neuroendocrine stress response-related circulating Mi-croRNAs as biomarkers for type 2 diabetes mellitus and insulin resistance","volume":"9","author":"Liang","year":"2018","journal-title":"Front. Endocrinol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1101\/gad.1800909","article-title":"Long noncoding RNAs: Functional surprises from the RNA world","volume":"23","author":"Wilusz","year":"2009","journal-title":"Genes Dev."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Marinescu, M.C., Lazar, A.L., Marta, M.M., Cozma, A., and Catana, C.S. (2022). Non-Coding RNAs: Prevention, Diagnosis, and Treatment in Myocardial Ischemia\u2013Reperfusion Injury. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23052728"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ncrna.2022.02.004","article-title":"Long noncoding RNAs as promising biomarkers in cancer","volume":"7","author":"Beylerli","year":"2022","journal-title":"Non-Coding RNA Res."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/10641955.2019.1573252","article-title":"New insight into the role of long non-coding RNAs in the pathogenesis of preeclampsia","volume":"38","author":"Moradi","year":"2019","journal-title":"Hypertens. Pregnancy"},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Pe\u00f1ailillo, R., Monteiro, L.J., Acu\u00f1a-Gallardo, S., Garc\u00eda, F., Vel\u00e1squez, V., Correa, P., D\u00edaz, P., Valdebenito, P.P., Navarro, C., and Romero, R. (2022). Identification of LOC101927355 as a Novel Biomarker for Preeclampsia. Biomedicines, 10.","DOI":"10.3390\/biomedicines10061253"},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Filardi, T., Catanzaro, G., Mardente, S., Zicari, A., Santangelo, C., Lenzi, A., Morano, S., and Ferretti, E. (2020). Non-Coding RNA: Role in Gestational Diabetes Pathophysiology and Complications. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21114020"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1177\/15353702231160327","article-title":"Circulating lncRNAs NONHSAT054669.2 and ENST00000525337 can be used as early biomarkers of gestational diabetes mellitus","volume":"248","author":"Jiang","year":"2023","journal-title":"Exp. Biol. Med."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"9945","DOI":"10.2147\/IJGM.S341106","article-title":"Long Non-Coding RNA HOTAIR Expression and Clinical Significance in Patients with Gestational Diabe-tes","volume":"14","author":"Su","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ijgo.12384","article-title":"Long non-coding RNA MALAT1 expression in patients with gestational diabetes mellitus","volume":"140","author":"Zhang","year":"2018","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0140-6736(93)92335-Q","article-title":"Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia","volume":"342","author":"Fickling","year":"1993","journal-title":"Lancet"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/107155760301000102","article-title":"Asymmetric Dimethylarginine, an Endogenous Inhibitor of Nitric Oxide Synthase, in Maternal and Fetal Circulation","volume":"10","author":"Maeda","year":"2003","journal-title":"J. Soc. Gynecol. Investig."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"H748","DOI":"10.1152\/ajpheart.1997.272.2.H748","article-title":"Nitric oxide-mediated vasodilation in human pregnancy","volume":"272","author":"Williams","year":"1997","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"ref_163","first-page":"38","article-title":"Asymmetric dimethylarginine, arginine and homoarginine at 11\u201313 weeks\u2019 gestation and preeclampsia: A case\u2013control study","volume":"27","author":"Tsikas","year":"2011","journal-title":"J. Hum. Hypertens."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Bian, Z., Shixia, C., and Duan, T. (2015). First-Trimester Maternal Serum Levels of sFLT1, PGF and ADMA Predict Preeclampsia. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0124684"},{"key":"ref_165","first-page":"639342","article-title":"Macrophage Migration Inhibitory Factor in Fetoplacental Tissues from Preeclamptic Pregnancies with or without Fetal Growth Restriction","volume":"2012","author":"Cardaropoli","year":"2012","journal-title":"J. Immunol. Res."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1210\/jc.2004-1512","article-title":"Placental Expression of Substance P and Vasoactive Intestinal Peptide: Evidence for a Local Effect on Hormone Release","volume":"90","author":"Marzioni","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4081\/1623","article-title":"Hyaluronate and CD44 expression patterns in the human placenta throughout pregnancy","volume":"45","author":"Marzioni","year":"2009","journal-title":"Eur. J. Histochem."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1002\/jcp.27344","article-title":"Pre-eclampsia onset and SPARC: A possible involvement in placenta development","volume":"234","author":"Tossetta","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"5581570","DOI":"10.1155\/2021\/5581570","article-title":"The Role of Oxidative Stress in Hypertensive Disorders of Pregnancy (Preeclampsia, Gestational Hypertension) and Metabolic Disorder of Pregnancy (Gestational Diabetes Mellitus)","volume":"2021","author":"Phoswa","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11892-015-0579-4","article-title":"Preeclampsia and Diabetes","volume":"15","author":"Weissgerber","year":"2015","journal-title":"Curr. Diabetes Rep."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1134\/S0012496623700722","article-title":"Morfofunctional and Molecular Changes in Placenta and Peripheral Blood in Preeclampsia and Gestational Diabetes Mellitus","volume":"513","author":"Artemieva","year":"2023","journal-title":"Dokl. Biol. Sci."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1530\/REP-20-0169","article-title":"Pro-angiogenic effects of pregnancy-specific glycoproteins in endothelial and extravillous trophoblast cells","volume":"160","author":"Rattila","year":"2020","journal-title":"Reproduction"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/11\/6136\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:52:31Z","timestamp":1760107951000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/11\/6136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,2]]},"references-count":172,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["ijms25116136"],"URL":"https:\/\/doi.org\/10.3390\/ijms25116136","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,2]]}}}